Characteristics and survival to discharge of patients with STEMI between a PPCI-capable hospital and a non-PPCI hospital: A prospective observational study

References

• Arntz HR, Bossaert LL, Danchin N, Nikolaou NI. European resuscitation guidelines for resuscitation 2010 section 5. Initial management of acute coronary syndromes. Resuscitation 2010;81:1353–63.
   Google Scholar
• Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al., for the Benestent Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease: Benestent Study Group. N Engl J Med. 1994;331:489–95.
   PubMed Web of Science ®Google Scholar
• Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al., for the Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease: Stent Restenosis Study Investigators. N Engl J Med. 1994;331: 496–501.
   PubMed Web of Science ®Google Scholar
• Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003;361:13–20.
   PubMed Web of Science ®Google Scholar
• Dalby M, Bouzamondo A, Lechat P, Montalescot G. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: A meta-analysis. Circulation 2003; 108:1809–14.
   PubMed Web of Science ®Google Scholar
• Peterson ED, Lansky AJ, Anstrom KJ, Muhlbaier LH, Popma JJ, Satler LF, et al. Evolving trends in interventional device use and outcomes: Results from the National Cardiovascular Network Database. Am Heart J. 2000;139:198–207.
   Google Scholar
• Widimský P, Groch L, Zelízko M, Aschermann M, Bednár F, Suryapranata H. Multicentre randomised trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J. 2000;21:823–31.
   PubMed Web of Science ®Google Scholar
• Bellinger RL, Califf RM, Mark DB, Weber RA, Collins P, Stone J, et al. Helicopter transport of patients during acute myocardial infarction. Am J Cardiol. 1988;61:718–22.
   PubMed Web of Science ®Google Scholar
• Zijlstra F, de Boer MJ, Hoorntje JC, Reiffers S, Reiber JH, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993;328:680–4.
   PubMed Web of Science ®Google Scholar
• Barron HV, Bowlby LJ, Breen T, Rogers WJ, Canto JG, Zhang Y, et al. Use of reperfusion therapy for acute myocardial infarction in the United States: Data from the National Registry of Myocardial Infarction 2. Circulation 1998;97:1150–6.
   PubMed Web of Science ®Google Scholar
• Bradley EH, Herrin J, Wang Y, Barton BA, Webster TR, Mattera JA, et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med. 2006;355: 2308–20.
   PubMed Web of Science ®Google Scholar
• Gross BW, Dauterman KW, Moran MG, Kotler TS, Schnugg SJ, Rostykus PS, et al. An approach to shorten time to infarct artery patency in patients with ST-segment elevation myocardial infarction. Am J Cardiol. 2007;99:1360–3.
   PubMed Web of Science ®Google Scholar
• Le May MR, So DY, Dionne R, Glover CA, Froeschl MP, Wells GA, et al. A citywide protocol for primary PCI in ST- segment elevation myocardial infarction. N Engl Med. 2008; 358:231–40.
   PubMed Web of Science ®Google Scholar
• Zijlstra F, Patel A, Jones M, Grines CL, Ellis S, Garcia E, et al. Clinical characteristics and outcome of patients with early (< 2 h), intermediate (2–4 h) and late (> 4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J. 2002;23:550–7.
   PubMed Web of Science ®Google Scholar
• Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. J Am Med Assoc. 2000;283:2941–7.
   PubMed Web of Science ®Google Scholar
• Terkelsen CJ, Sørensen JT, Maeng M, Jensen LO, Tilsted HH, Trautner S, et al. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. J Am Med Assoc. 2010;304:763–71.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: An overview of the randomised trials. Prog Cardiovasc Dis. 1985;27:335–71.
   PubMed Web of Science ®Google Scholar
• Chen ZM, Pan HC, Chen YP, Peto R, Collins R, Jiang LX, et al. COMMIT (clopidogrel and metoprolol in myocardial infarction trial) collaborative group. Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: Randomised placebo-controlled trial. Lancet 2005; 366:1622–32.
   PubMed Web of Science ®Google Scholar
• Steg PG, Bonnefoy E, Chabaud S, Lapostolle F, Dubien PY, Cristofini P, et al., Comparison of angioplasty and prehospital thrombolysis in acute myocardial infarction (CAPTIM) Investigators. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: Data from the CAPTIM randomised clinical trial. Circulation 2003;108:2851–6.
   PubMed Web of Science ®Google Scholar
• Fosbol EL, Granger CB, Jollis JG, Monk L, Lin L, Lytle BL, et al. The impact of a statewide pre-hospital STEMI strategy to bypass hospitals without percutaneous coronary intervention capability on treatment times. Circulation 2013;127:604–12.
   PubMed Web of Science ®Google Scholar
• Cannon CP, McCabe CH, Gibson CM, Ghali M, Sequeira RF, McKendall GR, et al. TNK-tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 10: A dose-ranging trial. Circulation 1997; 95:351–6.
   PubMed Web of Science ®Google Scholar
• De Luca G, Suryapranata H, Ottervanger JP, Antman EM. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: Every minute of delay counts. Circulation 2004;109:1223–5.
   PubMed Web of Science ®Google Scholar
• De Luca G, van't Hof AW, de Boer MJ, Ottervanger JP, Hoorntje JC, Gosselink AT, et al. Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty. Eur Heart J. 2004;25:1009–13.
   PubMed Web of Science ®Google Scholar
• Tarantini G, Cacciavillani L, Corbetti F, Ramondo A, Marra MP, Bacchiega E, et al. Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: A study performed with contrast-enhanced magnetic resonance. J Am Coll Cardiol. 2005;46:1229–35.
   PubMed Web of Science ®Google Scholar
• Boersma E. Primary coronary angioplasty vs. thrombolysis group. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J. 2006;27:779–88.
   PubMed Web of Science ®Google Scholar
• Stone GW, Dixon SR, Grines CL, Cox DA, Webb JG, Brodie BR, et al. Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials. Am J Cardiol. 2007;100:1370–5.
   Google Scholar